Cite
Characterization of SN38-resistant T47D breast cancer cell sublines overexpressing BCRP, MRP1, MRP2, MRP3, and MRP4
MLA
Hee-Jeong Lee, and Cheol-Hee Choi. “Characterization of SN38-Resistant T47D Breast Cancer Cell Sublines Overexpressing BCRP, MRP1, MRP2, MRP3, and MRP4.” BMC Cancer, vol. 22, no. 1, Mar. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....48052dbdbfb8622f48084b9041580bdc&authtype=sso&custid=ns315887.
APA
Hee-Jeong Lee, & Cheol-Hee Choi. (2021). Characterization of SN38-resistant T47D breast cancer cell sublines overexpressing BCRP, MRP1, MRP2, MRP3, and MRP4. BMC Cancer, 22(1).
Chicago
Hee-Jeong Lee, and Cheol-Hee Choi. 2021. “Characterization of SN38-Resistant T47D Breast Cancer Cell Sublines Overexpressing BCRP, MRP1, MRP2, MRP3, and MRP4.” BMC Cancer 22 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....48052dbdbfb8622f48084b9041580bdc&authtype=sso&custid=ns315887.